{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:59:19Z","timestamp":1785765559777,"version":"3.56.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["(No. 7252174)"],"award-info":[{"award-number":["(No. 7252174)"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["(320.6750.2024-13-59)"],"award-info":[{"award-number":["(320.6750.2024-13-59)"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04276-5","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:14:00Z","timestamp":1774440840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ferroptosis targeting: a novel therapeutic armamentarium in multiple myeloma"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7023-7159","authenticated-orcid":false,"given":"Yumin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"4276_CR1","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046\u201360.","journal-title":"N Engl J Med"},{"key":"4276_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"N van de Donk","year":"2021","unstructured":"van de Donk N, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397:410\u201327.","journal-title":"Lancet"},{"key":"4276_CR3","doi-asserted-by":"publisher","first-page":"1415224","DOI":"10.3389\/fphar.2024.1415224","volume":"15","author":"X Cao","year":"2024","unstructured":"Cao X, Xiang J, Zhang Q, et al. Multidimensional role of adapalene in regulating cell death in multiple myeloma. Front Pharmacol. 2024;15:1415224.","journal-title":"Front Pharmacol"},{"key":"4276_CR4","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S1470-2045(20)30756-7","volume":"22","author":"P Moreau","year":"2021","unstructured":"Moreau P, Kumar SK, San Miguel J, et al. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. Lancet Oncol. 2021;22:e105\u2013105118.","journal-title":"Lancet Oncol"},{"key":"4276_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.trecan.2024.06.002","volume":"10","author":"EG Gunes","year":"2024","unstructured":"Gunes EG, Gunes M, Yu J, et al. Targeting cancer stem cells in multiple myeloma. Trends Cancer. 2024;10:733\u201348.","journal-title":"Trends Cancer"},{"key":"4276_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"4276_CR7","doi-asserted-by":"publisher","first-page":"103211","DOI":"10.1016\/j.redox.2024.103211","volume":"75","author":"C Berndt","year":"2024","unstructured":"Berndt C, Alborzinia H, Amen VS, et al. Ferroptosis in health and disease. Redox Biol. 2024;75:103211.","journal-title":"Redox Biol"},{"key":"4276_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/cancers12040970","volume":"12","author":"J Bordini","year":"2020","unstructured":"Bordini J, Morisi F, Cerruti F, et al. Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies. Cancers (Basel). 2020;12:970.","journal-title":"Cancers (Basel)"},{"key":"4276_CR9","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"4276_CR10","doi-asserted-by":"publisher","first-page":"114861","DOI":"10.1016\/j.ejmech.2022.114861","volume":"244","author":"L Yin","year":"2022","unstructured":"Yin L, Liu P, Jin Y, et al. Ferroptosis-related small-molecule compounds in cancer therapy: Strategies and applications. Eur J Med Chem. 2022;244:114861.","journal-title":"Eur J Med Chem"},{"key":"4276_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang Y, Hu J, Wu S, et al. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. Signal Transduct Target Ther. 2023;8:449.","journal-title":"Signal Transduct Target Ther"},{"key":"4276_CR12","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.drup.2022.100916","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu X, Ren Z, et al. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat. 2023;66:100916.","journal-title":"Drug Resist Updat"},{"key":"4276_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-024-02088-7","volume":"23","author":"H Wang","year":"2024","unstructured":"Wang H, Fleishman JS, Cheng S, et al. Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance. Mol Cancer. 2024;23:177.","journal-title":"Mol Cancer"},{"key":"4276_CR14","doi-asserted-by":"publisher","first-page":"R1292","DOI":"10.1016\/j.cub.2020.09.068","volume":"30","author":"D Tang","year":"2020","unstructured":"Tang D, Kroemer G, Ferroptosis. Curr Biol. 2020;30:R1292. -1292R1297.","journal-title":"Curr Biol"},{"key":"4276_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"4276_CR16","first-page":"1188","volume":"181","author":"K Hadian","year":"2020","unstructured":"Hadian K, Stockwell BR, SnapShot. Ferroptosis Cell. 2020;181:1188\u2013e11881.","journal-title":"Ferroptosis Cell"},{"issue":"6","key":"4276_CR17","doi-asserted-by":"publisher","first-page":"e20210518","DOI":"10.1084\/jem.20210518","volume":"218","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, et al. Ferroptosis in infection, inflammation, and immunity. J Exp Med. 2021;218(6):e20210518.","journal-title":"J Exp Med"},{"key":"4276_CR18","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019;35:830\u201349.","journal-title":"Cancer Cell"},{"key":"4276_CR19","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, et al. Ferroptosis: machinery and regulation. Autophagy. 2021;17:2054\u201381.","journal-title":"Autophagy"},{"key":"4276_CR20","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82:2215\u201327.","journal-title":"Mol Cell"},{"key":"4276_CR21","doi-asserted-by":"crossref","unstructured":"Jacquemyn J, Ralhan I, Ioannou MS. Driving factors of neuronal ferroptosis. Trends Cell Biol. 2024;34(7):535-46.","DOI":"10.1016\/j.tcb.2024.01.010"},{"key":"4276_CR22","doi-asserted-by":"publisher","first-page":"590226","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen X, Yu C, Kang R, et al. Iron Metabolism in Ferroptosis. Front Cell Dev Biol. 2020;8:590226.","journal-title":"Front Cell Dev Biol"},{"key":"4276_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/ars.2021.0218","volume":"37","author":"S David","year":"2022","unstructured":"David S, Jhelum P, Ryan F, et al. Dysregulation of Iron Homeostasis in the Central Nervous System and the Role of Ferroptosis in Neurodegenerative Disorders. Antioxid Redox Signal. 2022;37:150\u201370.","journal-title":"Antioxid Redox Signal"},{"key":"4276_CR24","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon SJ, Winter GE, Musavi LS, et al. Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death. ACS Chem Biol. 2015;10:1604\u20139.","journal-title":"ACS Chem Biol"},{"key":"4276_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91\u20138.","journal-title":"Nat Chem Biol"},{"key":"4276_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390.","journal-title":"Nat Chem Biol"},{"key":"4276_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","volume":"4","author":"R Shah","year":"2018","unstructured":"Shah R, Shchepinov MS, Pratt DA. Resolving the Role of Lipoxygenases in the Initiation and Execution of Ferroptosis. ACS Cent Sci. 2018;4:387\u201396.","journal-title":"ACS Cent Sci"},{"key":"4276_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Y Zou","year":"2020","unstructured":"Zou Y, Li H, Graham ET, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16:302\u20139.","journal-title":"Nat Chem Biol"},{"key":"4276_CR29","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"M Conrad","year":"2019","unstructured":"Conrad M, Pratt DA. The chemical basis of ferroptosis. Nat Chem Biol. 2019;15:1137\u201347.","journal-title":"Nat Chem Biol"},{"key":"4276_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.chembiol.2020.03.013","volume":"27","author":"BR Stockwell","year":"2020","unstructured":"Stockwell BR, Jiang X. The Chemistry and Biology of Ferroptosis. Cell Chem Biol. 2020;27:365\u201375.","journal-title":"Cell Chem Biol"},{"issue":"9","key":"4276_CR31","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","volume":"26","author":"E Dai","year":"2024","unstructured":"Dai E, Chen X, Linkermann A, et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat Cell Biol. 2024;26(9):1447\u201357.","journal-title":"Nat Cell Biol"},{"key":"4276_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/ars.2007.9.49","volume":"9","author":"SW Ryter","year":"2007","unstructured":"Ryter SW, Kim HP, Hoetzel A, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007;9:49\u201389.","journal-title":"Antioxid Redox Signal"},{"key":"4276_CR33","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"4276_CR34","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.tcb.2023.04.005","volume":"33","author":"AF Dos Santos","year":"2023","unstructured":"Dos Santos AF, Fazeli G, Xavier da Silva TN, et al. Ferroptosis: mechanisms and implications for cancer development and therapy response. Trends Cell Biol. 2023;33(12):1062\u201376.","journal-title":"Trends Cell Biol"},{"key":"4276_CR35","first-page":"3826","volume":"22","author":"N Geng","year":"2018","unstructured":"Geng N, Shi BJ, Li SL, et al. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells. Eur Rev Med Pharmacol Sci. 2018;22:3826\u201336.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4276_CR36","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41418-019-0393-7","volume":"27","author":"PH Chen","year":"2020","unstructured":"Chen PH, Wu J, Ding CC, et al. Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death Differ. 2020;27:1008\u201322.","journal-title":"Cell Death Differ"},{"key":"4276_CR37","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","volume":"28","author":"WD Bao","year":"2021","unstructured":"Bao WD, Pang P, Zhou XT, et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer\u2019s disease. Cell Death Differ. 2021;28:1548\u201362.","journal-title":"Cell Death Differ"},{"key":"4276_CR38","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","volume":"26","author":"M Gao","year":"2016","unstructured":"Gao M, Monian P, Pan Q, et al. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26:1021\u201332.","journal-title":"Cell Res"},{"key":"4276_CR39","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12:1425\u20138.","journal-title":"Autophagy"},{"key":"4276_CR40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, et al. Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell. 2015;59:298\u2013308.","journal-title":"Mol Cell"},{"key":"4276_CR41","doi-asserted-by":"publisher","first-page":"115015","DOI":"10.1016\/j.ejmech.2022.115015","volume":"247","author":"Y Gu","year":"2023","unstructured":"Gu Y, Li Y, Wang J, et al. Targeting ferroptosis: Paving new roads for drug design and discovery. Eur J Med Chem. 2023;247:115015.","journal-title":"Eur J Med Chem"},{"key":"4276_CR42","doi-asserted-by":"publisher","first-page":"e2300325","DOI":"10.1002\/advs.202300325","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu S, Li Q, et al. Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes. Adv Sci (Weinh). 2023;10:e2300325.","journal-title":"Adv Sci (Weinh)"},{"key":"4276_CR43","doi-asserted-by":"publisher","first-page":"904152","DOI":"10.3389\/fnagi.2022.904152","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun Y, Xia X, Basnet D, et al. Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases. Front Aging Neurosci. 2022;14:904152.","journal-title":"Front Aging Neurosci"},{"key":"4276_CR44","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392.","journal-title":"Nature"},{"key":"4276_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138.","journal-title":"Nature"},{"key":"4276_CR46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","volume":"619","author":"T Nakamura","year":"2023","unstructured":"Nakamura T, Hipp C, Santos Dias Mour\u00e3o A, et al. Phase separation of FSP1 promotes ferroptosis. Nature. 2023;619:371\u20137.","journal-title":"Nature"},{"key":"4276_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"V Kraft","year":"2020","unstructured":"Kraft V, Bezjian CT, Pfeiffer S, et al. GTP Cyclohydrolase 1\/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling. ACS Cent Sci. 2020;6:41\u201353.","journal-title":"ACS Cent Sci"},{"key":"4276_CR48","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula M, Weber RA, Zilka O, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16:1351\u201360.","journal-title":"Nat Chem Biol"},{"issue":"7860","key":"4276_CR49","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390.","journal-title":"Nature"},{"key":"4276_CR50","doi-asserted-by":"crossref","unstructured":"Liang D, Feng Y, Zandkarimi F et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186(13):2748-64.e22.","DOI":"10.1016\/j.cell.2023.05.003"},{"key":"4276_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","volume":"626","author":"FP Freitas","year":"2024","unstructured":"Freitas FP, Alborzinia H, Dos Santos AF, et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature. 2024;626:401\u201310.","journal-title":"Nature"},{"key":"4276_CR52","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41586-023-06983-9","volume":"626","author":"Y Li","year":"2024","unstructured":"Li Y, Ran Q, Duan Q, et al. 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature. 2024;626:411\u20138.","journal-title":"Nature"},{"key":"4276_CR53","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","volume":"67","author":"S Meister","year":"2007","unstructured":"Meister S, Schubert U, Neubert K, et al. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition. Cancer Res. 2007;67:1783\u201392.","journal-title":"Cancer Res"},{"key":"4276_CR54","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/leu.2016.346","volume":"31","author":"J Bordini","year":"2017","unstructured":"Bordini J, Galvan S, Ponzoni M, et al. Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma. Leukemia. 2017;31:967\u201370.","journal-title":"Leukemia"},{"key":"4276_CR55","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3324\/haematol.2012.074872","volume":"98","author":"A Campanella","year":"2013","unstructured":"Campanella A, Santambrogio P, Fontana F, et al. Iron increases the susceptibility of multiple myeloma cells to bortezomib. Haematologica. 2013;98:971\u20139.","journal-title":"Haematologica"},{"key":"4276_CR56","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/carcin\/bgad015","volume":"44","author":"J Zhang","year":"2023","unstructured":"Zhang J, Liu Y, Li Q, et al. ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis. Carcinogenesis. 2023;44:242\u201351.","journal-title":"Carcinogenesis"},{"key":"4276_CR57","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s10495-023-01909-2","volume":"29","author":"W Zhang","year":"2024","unstructured":"Zhang W, Li Q, Zhang Y, et al. Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis. Apoptosis. 2024;29:412\u201323.","journal-title":"Apoptosis"},{"key":"4276_CR58","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41388-024-03020-5","volume":"43","author":"H Jiang","year":"2024","unstructured":"Jiang H, Wang L, Zhang Q, et al. Bone marrow stromal cells dictate lanosterol biosynthesis and ferroptosis of multiple myeloma. Oncogene. 2024;43:1644\u201353.","journal-title":"Oncogene"},{"key":"4276_CR59","doi-asserted-by":"publisher","first-page":"217388","DOI":"10.1016\/j.canlet.2024.217388","volume":"611","author":"H Jiang","year":"2024","unstructured":"Jiang H, Li Q, Yang X, et al. Bone marrow stromal cells protect myeloma cells from ferroptosis through GPX4 deSUMOylation. Cancer Lett. 2024;611:217388.","journal-title":"Cancer Lett"},{"key":"4276_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","volume":"15","author":"DF Quail","year":"2019","unstructured":"Quail DF, Dannenberg AJ. The obese adipose tissue microenvironment in cancer development and progression. Nat Rev Endocrinol. 2019;15:139\u201354.","journal-title":"Nat Rev Endocrinol"},{"key":"4276_CR61","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1182\/blood.2021013832","volume":"139","author":"C Panaroni","year":"2022","unstructured":"Panaroni C, Fulzele K, Mori T, et al. Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins. Blood. 2022;139:876\u201388.","journal-title":"Blood"},{"key":"4276_CR62","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1038\/s41467-024-50073-x","volume":"15","author":"M Xian","year":"2024","unstructured":"Xian M, Wang Q, Xiao L, et al. Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nat Commun. 2024;15:5767.","journal-title":"Nat Commun"},{"key":"4276_CR63","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/bjh.19375","volume":"204","author":"M Li","year":"2024","unstructured":"Li M, Zhang CL, Zhou DS, et al. Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells. Br J Haematol. 2024;204:1307\u201324.","journal-title":"Br J Haematol"},{"key":"4276_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17474086.2025.2492881","volume":"21","author":"G Hu","year":"2025","unstructured":"Hu G, Zhang H, Wang Y, et al. PRDX6 knockdown sensitizes multiple myeloma cells to ferroptosis through inactivation of the PI3K\/AKT pathway. Expert Rev Hematol. 2025;21:1\u201310. https:\/\/doi.org\/10.1080\/17474086.2025.2492881.","journal-title":"Expert Rev Hematol"},{"key":"4276_CR65","doi-asserted-by":"publisher","first-page":"115720","DOI":"10.1016\/j.celrep.2025.115720","volume":"44","author":"N Shen","year":"2025","unstructured":"Shen N, Xia Y, Shen X, et al. HSPA9 contributes to tumor progression and ferroptosis resistance by enhancing USP14-driven SLC7A11 deubiquitination in multiple myeloma. Cell Rep. 2025;44:115720.","journal-title":"Cell Rep"},{"key":"4276_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1615\/CritRevEukaryotGeneExpr.2024056835","volume":"35","author":"T Guo","year":"2025","unstructured":"Guo T, Zhang F, Wang H, et al. DUBR\/miR-17-3p\/TFRC\/HO-1 Axis Promotes the Chemosensitivity of Multiple Myeloma. Crit Rev Eukaryot Gene Expr. 2025;35:51\u201362.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"4276_CR67","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/sj.leu.2404524","volume":"21","author":"WJ Chng","year":"2007","unstructured":"Chng WJ, Price-Troska T, Gonzalez-Paz N, et al. Clinical significance of TP53 mutation in myeloma. Leukemia. 2007;21:582\u20134.","journal-title":"Leukemia"},{"key":"4276_CR68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41375-018-0196-8","volume":"33","author":"BA Walker","year":"2019","unstructured":"Walker BA, Mavrommatis K, Wardell CP, et al. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis. Leukemia. 2019;33:159\u201370.","journal-title":"Leukemia"},{"key":"4276_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57\u201362.","journal-title":"Nature"},{"key":"4276_CR70","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2016.09.022","volume":"17","author":"SJ Wang","year":"2016","unstructured":"Wang SJ, Li D, Ou Y, et al. Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression. Cell Rep. 2016;17:366\u201373.","journal-title":"Cell Rep"},{"key":"4276_CR71","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.celrep.2017.12.077","volume":"22","author":"A Tarangelo","year":"2018","unstructured":"Tarangelo A, Magtanong L, Bieging-Rolett KT, et al. p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells. Cell Rep. 2018;22:569\u201375.","journal-title":"Cell Rep"},{"key":"4276_CR72","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","volume":"20","author":"Y Xie","year":"2017","unstructured":"Xie Y, Zhu S, Song X, et al. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity. Cell Rep. 2017;20:1692\u2013704.","journal-title":"Cell Rep"},{"key":"4276_CR73","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137.","journal-title":"Nature"},{"key":"4276_CR74","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551:247\u201350.","journal-title":"Nature"},{"key":"4276_CR75","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/med.21933","volume":"43","author":"SC Koeberle","year":"2023","unstructured":"Koeberle SC, Kipp AP, Stuppner H, et al. Ferroptosis-modulating small molecules for targeting drug-resistant cancer: Challenges and opportunities in manipulating redox signaling. Med Res Rev. 2023;43:614\u201382.","journal-title":"Med Res Rev"},{"key":"4276_CR76","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1016\/j.apsb.2024.05.025","volume":"14","author":"AT Kao","year":"2024","unstructured":"Kao AT, Cabanlong CV, Padilla K, et al. Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment. Acta Pharm Sin B. 2024;14:3785\u2013801.","journal-title":"Acta Pharm Sin B"},{"key":"4276_CR77","doi-asserted-by":"crossref","unstructured":"Lin J, Lai Y, Lu F et al. Targeting ACSLs to modulate ferroptosis and cancer immunity. Trends Endocrinol Metab. 2025;36(7):677-90 .","DOI":"10.1016\/j.tem.2024.09.003"},{"key":"4276_CR78","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/ars.2024.0608","volume":"41","author":"TA Muluh","year":"2024","unstructured":"Muluh TA, Fu Q, Ai X, et al. Targeting Ferroptosis as an Advance Strategy in Cancer Therapy. Antioxid Redox Signal. 2024;41:616\u201336.","journal-title":"Antioxid Redox Signal"},{"key":"4276_CR79","first-page":"41","volume":"7","author":"D Tang","year":"2024","unstructured":"Tang D, Kang R. NFE2L2 and ferroptosis resistance in cancer therapy. Cancer Drug Resist. 2024;7:41.","journal-title":"Cancer Drug Resist"},{"key":"4276_CR80","doi-asserted-by":"publisher","first-page":"1290183","DOI":"10.3389\/fphar.2024.1290183","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Hu J, Fleishman JS, et al. Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer. Front Pharmacol. 2024;15:1290183.","journal-title":"Front Pharmacol"},{"key":"4276_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20517\/cdr.2024.151","volume":"8","author":"Y Yang","year":"2025","unstructured":"Yang Y, Yu S, Liu W, et al. Ferroptosis-related signaling pathways in cancer drug resistance. Cancer Drug Resist. 2025;8:1.","journal-title":"Cancer Drug Resist"},{"issue":"4\u20136","key":"4276_CR82","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/ars.2024.0807","volume":"43","author":"J Zhang","year":"2025","unstructured":"Zhang J, Wang Y, Fleishman JS, et al. Small Molecules Targeting Non-Coding RNAs Regulating Ferroptosis: New Opportunities in Precision Cancer Therapy. Antioxid Redox Signal. 2025;43(4\u20136):345\u201362.","journal-title":"Antioxid Redox Signal"},{"key":"4276_CR83","doi-asserted-by":"publisher","first-page":"107729","DOI":"10.1016\/j.phrs.2025.107729","volume":"215","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Lu L, Chen X, et al. Natural compounds targeting ferroptosis in ovarian cancer: Research progress and application potential. Pharmacol Res. 2025;215:107729.","journal-title":"Pharmacol Res"},{"key":"4276_CR84","doi-asserted-by":"publisher","first-page":"153371","DOI":"10.1016\/j.phymed.2020.153371","volume":"80","author":"AN Adham","year":"2021","unstructured":"Adham AN, Abdelfatah S, Naqishbandi AM, et al. Cytotoxicity of apigenin toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells. Phytomedicine. 2021;80:153371.","journal-title":"Phytomedicine"},{"key":"4276_CR85","doi-asserted-by":"publisher","first-page":"109622","DOI":"10.1016\/j.abb.2023.109622","volume":"742","author":"W Li","year":"2023","unstructured":"Li W, Fu H, Fang L, et al. Andrographolide induced ferroptosis in multiple myeloma cells by regulating the P38\/Nrf2\/HO-1 pathway. Arch Biochem Biophys. 2023;742:109622.","journal-title":"Arch Biochem Biophys"},{"key":"4276_CR86","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/1440-1681.13805","volume":"50","author":"Q Ying","year":"2023","unstructured":"Ying Q, Lou J, Zheng D. Ginsenoside Rh4 inhibits the malignant progression of multiple myeloma and induces ferroptosis by regulating SIRT2. Clin Exp Pharmacol Physiol. 2023;50:757\u201365.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4276_CR87","doi-asserted-by":"publisher","first-page":"1025067","DOI":"10.3389\/fonc.2022.1025067","volume":"12","author":"W Li","year":"2022","unstructured":"Li W, Fu H, Fang L, et al. Shikonin induces ferroptosis in multiple myeloma via GOT1-mediated ferritinophagy. Front Oncol. 2022;12:1025067.","journal-title":"Front Oncol"},{"key":"4276_CR88","doi-asserted-by":"publisher","first-page":"113458","DOI":"10.1016\/j.jep.2020.113458","volume":"266","author":"AN Adham","year":"2021","unstructured":"Adham AN, Naqishbandi AM, Efferth T. Cytotoxicity and apoptosis induction by Fumaria officinalis extracts in leukemia and multiple myeloma cell lines. J Ethnopharmacol. 2021;266:113458.","journal-title":"J Ethnopharmacol"},{"key":"4276_CR89","doi-asserted-by":"publisher","first-page":"155401","DOI":"10.1016\/j.phymed.2024.155401","volume":"128","author":"W Li","year":"2024","unstructured":"Li W, Yin X, Fu H, et al. Ethanol extract of Eclipta prostrata induces multiple myeloma ferroptosis via Keap1\/Nrf2\/HO-1 axis. Phytomedicine. 2024;128:155401.","journal-title":"Phytomedicine"},{"key":"4276_CR90","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.freeradbiomed.2023.04.003","volume":"203","author":"Z Yin","year":"2023","unstructured":"Yin Z, Lv Y, Deng L, et al. Targeting ABCB6 with nitidine chloride inhibits PI3K\/AKT signaling pathway to promote ferroptosis in multiple myeloma. Free Radic Biol Med. 2023;203:86\u2013101.","journal-title":"Free Radic Biol Med"},{"key":"4276_CR91","doi-asserted-by":"publisher","first-page":"119454","DOI":"10.1016\/j.jep.2025.119454","volume":"343","author":"J Yang","year":"2025","unstructured":"Yang J, Wang F, Hu Z, et al. Huachansu Injection induces ferroptosis in multiple myeloma through NRF2\/HO-1 signaling pathway. J Ethnopharmacol. 2025;343:119454.","journal-title":"J Ethnopharmacol"},{"key":"4276_CR92","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1007\/s00277-024-05762-4","volume":"103","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, He F, Hu W, et al. Bortezomib elevates intracellular free Fe(2+) by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells. Ann Hematol. 2024;103:3627\u201337.","journal-title":"Ann Hematol"},{"key":"4276_CR93","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/10428194.2024.2422843","volume":"66","author":"C Arkan","year":"2025","unstructured":"Arkan C, Akcora-Yildiz D. FDA-approved disulfiram induces ferroptosis via alteration of redox balance and lipid peroxidation and overcomes carfilzomib resistance in multiple myeloma. Leuk Lymphoma. 2025;66:250\u201361.","journal-title":"Leuk Lymphoma"},{"key":"4276_CR94","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.7150\/ijms.86409","volume":"20","author":"L Liang","year":"2023","unstructured":"Liang L, Liu Y, Wu X, et al. Artesunate induces ferroptosis by inhibiting the nuclear localization of SREBP2 in myeloma cells. Int J Med Sci. 2023;20:1535\u201350.","journal-title":"Int J Med Sci"},{"key":"4276_CR95","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1182\/bloodadvances.2023010335","volume":"8","author":"J Zhang","year":"2024","unstructured":"Zhang J, Liu Y, Zuo L, et al. Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma. Blood Adv. 2024;8:5022\u201338.","journal-title":"Blood Adv"},{"key":"4276_CR96","doi-asserted-by":"publisher","first-page":"e34397","DOI":"10.1016\/j.heliyon.2024.e34397","volume":"10","author":"S Tang","year":"2024","unstructured":"Tang S, Liu J, Li F, et al. AP-1 inhibitor induces ferroptosis via the PI3K\/AKT pathway in multiple myeloma cells. Heliyon. 2024;10:e34397.","journal-title":"Heliyon"},{"key":"4276_CR97","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00277-024-05728-6","volume":"103","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang X, Li X, et al. Novel methyltransferase G9a inhibitor induces ferroptosis in multiple myeloma through Nrf2\/HO-1 pathway. Ann Hematol. 2024;103:2405\u201317.","journal-title":"Ann Hematol"},{"key":"4276_CR98","doi-asserted-by":"publisher","first-page":"118077","DOI":"10.1016\/j.lfs.2020.118077","volume":"260","author":"Y Zhong","year":"2020","unstructured":"Zhong Y, Tian F, Ma H, et al. FTY720 induces ferroptosis and autophagy via PP2A\/AMPK pathway in multiple myeloma cells. Life Sci. 2020;260:118077.","journal-title":"Life Sci"},{"key":"4276_CR99","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/cells10092287","volume":"10","author":"J Chen","year":"2021","unstructured":"Chen J, Zaal EA, Berkers CR, et al. Omega-3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation. Cells. 2021;10:2287.","journal-title":"Cells"},{"key":"4276_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13402-023-00858-x","volume":"47","author":"YC Liu","year":"2024","unstructured":"Liu YC, Gong YT, Sun QY, et al. Ferritinophagy induced ferroptosis in the management of cancer. Cell Oncol (Dordr). 2024;47:19\u201335.","journal-title":"Cell Oncol (Dordr)"},{"issue":"6","key":"4276_CR101","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s13402-023-00840-7","volume":"46","author":"J Lee","year":"2023","unstructured":"Lee J, Roh JL. Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy. Cell Oncol (Dordr). 2023;46(6):1605\u201323.","journal-title":"Cell Oncol (Dordr)"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04276-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:03:05Z","timestamp":1778011385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04276-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4276"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04276-5","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}